# A Study of Single and Multiple Doses of LP-003 in Healthy Adult Participants

> **NCT06294288** · PHASE1 · COMPLETED · sponsor: **Longbio Pharma** · enrollment: 60 (actual)

## Conditions studied

- Chronic Spontaneous Urticaria

## Interventions

- **BIOLOGICAL:** LP-003 Dose 1 (Single)
- **BIOLOGICAL:** LP-003 Dose 2 (Single)
- **BIOLOGICAL:** LP-003 Dose 3 (Single)
- **BIOLOGICAL:** LP-003 Dose 4 (Single)
- **BIOLOGICAL:** LP-003 Dose 5 (Single)
- **BIOLOGICAL:** Placebo (Single)
- **BIOLOGICAL:** LP-003 Dose 6 (Multiple)
- **BIOLOGICAL:** LP-003 Dose 7 (Multiple)
- **BIOLOGICAL:** LP-003 Dose 8 (Multiple)
- **BIOLOGICAL:** Placebo (Multiple)

## Key facts

- **NCT ID:** NCT06294288
- **Lead sponsor:** Longbio Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-07-13
- **Primary completion:** 2024-03-04
- **Final completion:** 2024-03-04
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2025-12-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06294288

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06294288, "A Study of Single and Multiple Doses of LP-003 in Healthy Adult Participants". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT06294288. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*